Revenue
$5.54B
Gross Margin
+61.7%
Operating Margin
+34.3%
Net Margin
+27.4%
Income statement waterfall for ResMed (RMD) — TTM through Q1 2026
Net income: $1.52B
Margin breakdown for ResMed (RMD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $5.54B | $5.54B |
| Cost of Revenue | −$2.12B | $3.42B |
| Gross Profit | $3.42B | $3.42B |
| Operating Expenses | −$1.52B | $1.90B |
| Operating Income | $1.90B | $1.90B |
| Other Income / Expense | $4.82M | $1.90B |
| Pre-tax Income | $1.90B | $1.90B |
| Income Tax | −$383.74M | $1.52B |
| Net Income | $1.52B | $1.52B |
- Revenue$5.54B
- Cost of Revenue−$2.12B
- Gross Profit$3.42B
- Operating Expenses−$1.52B
- Operating Income$1.90B
- Other Income / Expense$4.82M
- Pre-tax Income$1.90B
- Income Tax−$383.74M
- Net Income$1.52B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement